Gauthami Pulivendala | Translational Research | Young Researcher Award

Dr. Gauthami Pulivendala | Translational Research | Young Researcher Award

Postdoc Associate | University of Miami | United States

Dr. Gauthami Pulivendala is a researcher at Sylvester Comprehensive Cancer Center, specializing in cancer biology, fibrosis, and molecular signaling pathways. Her work focuses on understanding mechanisms such as the ChREBPα-mediated regulation of hepatic stellate cell activation and its role in liver fibrosis, contributing to advancements in translational oncology. With 11 publications, 318 citations, and an h-index of 9, she demonstrates strong research impact and scientific productivity. Collaborating with an extensive network of co-authors, her research reflects interdisciplinary engagement across cancer biology and metabolic disease domains. Her contributions hold significant societal value by advancing knowledge in fibrosis and tumor microenvironment interactions, supporting the development of targeted therapies, and improving clinical strategies for cancer and liver-related diseases, thereby contributing to global health innovation and patient care outcomes.

Citation Metrics (Scopus)

318
240
160
80
0

Citations

318

Documents

11

h-index

9

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications


Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases

– Drug Delivery and Translational Research, 2020 | Citations: 62

Yang Zhang | Clinical Medicine | Best Researcher Award

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.